A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Clinical trials in Tyler, TX: what is studied
Cancer. Cancer research makes up a large share of the studies in Tyler, most of it through Texas Oncology and the UT Health East Texas HOPE Cancer Center. Studies often cover common cancers such as lung cancer, breast cancer, and colorectal cancer, along with gynecologic and blood cancers; see our oncology clinical trials page.
Digestive diseases. Tyler Research Institute is a dedicated research site, and many of its studies are for people with Crohn's disease and ulcerative colitis.
Our guide to Crohn's treatment explains what is approved today.
Heart, metabolic, and other conditions. Local cardiology practices take part in heart failure and other heart studies, and studies in obesity, type 2 diabetes, eye disease, and asthma also recruit in the city. Our weight loss clinical trials page lists studies of new weight loss medicines.
Do clinical trials in Tyler pay?
Some studies offer compensation for time and travel, and study related care is typically provided at no cost to participants. Compensation varies by trial and is always described during the informed consent process before you agree to anything. The institutional review board (IRB) that oversees each study reviews the amount and timing of any payment, and FDA guidance says payment should build up as the study goes on rather than depend on finishing it. Many studies at least cover travel, which matters for people who drive in from smaller towns across East Texas.
Our guide explains how much clinical trials pay and how payment is decided.
How to join a clinical trial in Tyler
- Identify your trial. Use the filters on this page to narrow the list by condition or phase, or search a diagnosis such as Crohn's disease or lung cancer.
- Check the location. Each study lists the sites where it recruits, so confirm it has a site in Tyler and not only in Dallas or Houston.
- Explore study details. Read the eligibility criteria and, where listed, the number of visits and how long the study lasts before applying.
- Complete the health profile. Click "See if you qualify" to begin the 5-step application. Have ready your diagnosis and when it was made, the medicines you take, and any recent test results.
- Submit the application. A clinical trial coordinator reviews it and contacts you to discuss next steps. Nothing is decided until informed consent, and participation is voluntary at every step.
Our guide to finding clinical trials near you covers each step in more detail.
Do I need health insurance to join a clinical trial?
Not always. Study related care, including the study medicine and the visits and tests the protocol requires, is typically provided at no cost to participants. Routine care you would receive anyway may be billed to your insurance, and the study team explains what is covered before you sign anything. Our guide to insurance for clinical trials covers the details.
Clinical trials near Tyler and across Texas
If nothing in Tyler fits, our Dallas clinical trials page lists the larger research programs about 100 miles west, and our Dallas clinical trials guide explains the city's main institutions. Shreveport, about 100 miles east in Louisiana, has its own page, and studies across the state are on our Texas clinical trials page.